In the biotechnology field, Chris and James Hengst, President & CEO, purchased Cellular Products Inc. and formed ZeptoMetrix in July 1999 followed by the April 2004 purchase of Impath BioClinical Partners located in Franklin, MA. In addition to ZeptoMetrix, Chris and Jim formed Buckler Biodefense Corporation in 2006 in partnership with Virionyx, Ltd., located in Auckland, New Zealand http://www.zeptometrix.com/zeptogramwinter07.pdf
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.